Text Size

Efficacy and safety of a cationic emulsion in the treatment of moderate to severe dry eye disease: A randomized controlled study

Robert P.-Y., Cochener B., Amrane M., Ismail D., Garrigue J.-S., Pisella P.-J., Baudouin C.


  • 2016
  • European Journal of Ophthalmology
View publication
  • Therapeutic Area

    Front of the eye (FOTE)

  • Categories

    Clinical development

  • Affiliations

    Department of Ophthalmology, Dupuytren University Hospital, Limoges, France; Brest University Medical School, Department of Ophthalmology, Morvan Hospital, Brest, France; Santen SAS, Evry, France; François Rabelais University, Tours, France; Department of Ophthalmology, Bretonneau Hospital, Tours, France; Quinze-Vingts National Ophthalmology Hospital, Paris, France; UPMC University, Paris 6, Vision Institute, INSERM UMRS968, CNRS UMR7210, Paris, France; University of Versailles, Saint-Quentin en Yvelines, Versailles, France

Related Publications

Burden of Vernal Keratoconjunctivitis in the United States: A Retrospective Claims Database Analysis

Koo E.B.; Yu T.M.; Layton A.J.; Babineaux S.; Fung S.


Review of clinical outcomes of a cationic emulsion tear substitute in patients with dry eye disease

Labetoulle M, Garhöfer G, Ismail D, Garrigue JS, Amrane M, Guillon M, Aragona P, Baudouin C.


Epinastine Cream: A Novel Once-Daily Therapeutic Agent for Allergic Conjunctivitis

Ogura N., Fujisawa K., Kato M.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022